Additive effects of eldecalcitol in poorly responding long-term bisphosphonate treatment for osteoporosis
{{output}}
Objectives: We examined whether eldecalcitol (ELD) provided additive bone mineral density (BMD) and bone turnover marker gains in patients undergoing long-term bisphosphonate (BP) usage, especially in osteoporotic individuals exh... ...
